Spirapril
Spirapril is a potent and cross the blood-brain barrier angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Spirapril competitively binds to ACE and prevents the conversion of angiotensin I to angiotensin II. Spirapril is an orally active proagent of Spiraprilat and can be used for the research of hypertension, congestive heart failure[1][2][3].
Product Specifications
CAS Number
83647-97-6
Product Name Alternative
SCH 33844
UNSPSC
12352005
Hazard Statement
H302-H312-H332
Target
Angiotensin-converting Enzyme (ACE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/spirapril.html
Solubility
10 mM in DMSO
Smiles
CCOC([C@H](CCC1=CC=CC=C1)N[C@@H](C)C(N2CC3(SCCS3)C[C@H]2C(O)=O)=O)=O
Molecular Formula
C22H30N2O5S2
Molecular Weight
466.61
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![(3S,5R) -[ (1H-1,2,4-Triazol-1-yl) -methyl-5- (2,4-difluorophenyl) tetrahydrofuran-3-yl]methyl Isobutyrate](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
(3S,5R) -[ (1H-1,2,4-Triazol-1-yl) -methyl-5- (2,4-difluorophenyl) tetrahydrofuran-3-yl]methyl Isobutyrate
(3S,5R) -[ (1H-1,2,4-Triazol-1-yl) -methyl-5- (2,4-difluorophenyl) tetrahydrofuran-3-yl]methyl Isobutyrate
